跳轉至內容
Merck
  • PI3K signalling in GnRH actions on dispersed goldfish pituitary cells: relationship with PKC-mediated LH and GH release and regulation of long-term effects on secretion and total cellular hormone availability.

PI3K signalling in GnRH actions on dispersed goldfish pituitary cells: relationship with PKC-mediated LH and GH release and regulation of long-term effects on secretion and total cellular hormone availability.

General and comparative endocrinology (2014-04-01)
Joshua G Pemberton, Michael E Orr, James L Stafford, John P Chang
摘要

Goldfish pituitary cells are exposed to two GnRHs, salmon (s)GnRH and chicken (c)GnRH-II. Phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) both participate in acute sGnRH- and cGnRH-II-stimulated LH and GH release. Using goldfish pituitary cells, we examined the relationship between PI3K and PKC in acute LH and GH secretion, and PI3K involvement in chronic hormone release and total LH and GH availability. The PI3K inhibitor LY294002 did not affect PKC agonists-induced LH or GH release, and PKC agonists did not alter PI3K p85 phosphorylation, suggesting PKC activation is not upstream of PI3K in acute hormone release. In 2, 6, 12 and 24h treatments, LY294002 did not affect LH release but stimulated total LH availability at 6h. sGnRH stimulatory actions on LH release and total availability at 12 and 24h, and cGnRH-II effects on these parameters at 6h were inhibited by LY294002. LY294002 enhanced basal GH release at 2 and 6h, but reduced total GH at 12 and 24h. Increased GH release was seen following 6, 12 and 24h of sGnRH, and 2, 6 and 24h of cGnRH-II treatment but total GH availability was only elevated by 24h cGnRH-II treatment. Whereas LY294002 inhibited GH release responses to sGnRH at 12h and cGnRH-II at 6h, it attenuated cGnRH-II-elicited, but not sGnRH-induced, effects on total GH. These results indicate that PI3K differentially modulates long-term basal and GnRH-stimulated hormone release, and total hormone availability, in a time-, cell-type-, and GnRH isoform-selective manner.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
甘氨酸, ReagentPlus®, ≥99% (HPLC)
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, suitable for electrophoresis, ≥99%
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, BioUltra, for molecular biology, ≥99.0% (NT)
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
登入查看組織和合約定價
SAFC
甘氨酸
登入查看組織和合約定價
USP
甘氨酸, United States Pharmacopeia (USP) Reference Standard
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, BioXtra, ≥99% (titration)
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, 99%, FCC
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, ACS reagent, ≥98.5%
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)
登入查看組織和合約定價
Supelco
甘氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
登入查看組織和合約定價
Supelco
甘氨酸, analytical standard, for nitrogen determination according to Kjeldahl method
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, puriss. p.a., reag. Ph. Eur., buffer substance, 99.7-101% (calc. to the dried substance)
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, Vetec, reagent grade, 98%
登入查看組織和合約定價
甘氨酸, European Pharmacopoeia (EP) Reference Standard
登入查看組織和合約定價
Supelco
甘氨酸, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
登入查看組織和合約定價
Sigma-Aldrich
甘氨酸, tested according to Ph. Eur.
登入查看組織和合約定價